Literature DB >> 8226783

Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line.

H Otani1, M Erdos, W J Leonard.   

Abstract

Apoptosis (programmed cell death) plays a critical role in many physiological processes, but the mechanism(s) which regulate apoptosis are poorly understood. We demonstrate that in a hematopoietic cell line, which can grow in either interleukin (IL)-2 or IL-3, both of these growth factors can increase bcl-2 mRNA levels and prevent apoptosis normally seen following growth factor withdrawal. Herbimycin A, a protein tyrosine kinase inhibitor, blocks the ability of IL-2 and IL-3 to up-regulate bcl-2 mRNA levels and induces apoptosis. Transfection of a bcl-2 expression vector not only prolongs survival following growth factor withdrawal but also confers resistance to the effect of herbimycin A. We conclude that herbimycin A-sensitive protein tyrosine kinases are involved in the regulation of apoptosis and bcl-2 expression, but these protein tyrosine kinases appear not to be required for the action of Bcl-2 since Bcl-2 can exert its growth survival effect even in the presence of herbimycin A.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226783

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

Authors:  T Skorski; A Bellacosa; M Nieborowska-Skorska; M Majewski; R Martinez; J K Choi; R Trotta; P Wlodarski; D Perrotti; T O Chan; M A Wasik; P N Tsichlis; B Calabretta
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain.

Authors:  M Noguchi; A Sarin; M J Aman; H Nakajima; E W Shores; P A Henkart; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

Review 4.  Programmed cell death--many questions still to be answered.

Authors:  C Binder; W Hiddemann
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

5.  Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor.

Authors:  Y T Huang; J J Hwang; P P Lee; F C Ke; J H Huang; C J Huang; C Kandaswami; E Middleton; M T Lee
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.

Authors:  M C Friedmann; T S Migone; S M Russell; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Tyrosine phosphorylation participates in peripheral T-cell activation and programmed cell death in vivo.

Authors:  K Migita; K Eguchi; Y Kawabe; S Nagataki
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cells.

Authors:  D E Myers; X Jun; K G Waddick; C Forsyth; L M Chelstrom; R L Gunther; N E Tumer; J Bolen; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

9.  Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils.

Authors:  S Yousefi; D R Green; K Blaser; H U Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Herpes simplex virus type 1 blocks the apoptotic host cell defense mechanisms that target Bcl-2 and manipulates activation of p38 mitogen-activated protein kinase to improve viral replication.

Authors:  G Zachos; M Koffa; C M Preston; J B Clements; J Conner
Journal:  J Virol       Date:  2001-03       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.